2026-04-22 20:13 UTC / 路透社
路透社报道
2026年4月22日 20:13 UTC 2小时前更新
节点运行失败
华盛顿4月22日路透电 —— Axios援引一位知情官员消息报道，美国政府最早将于周三调整大麻的分类标准，这一消息推动美国大麻相关企业股价上涨。
此次大麻分类调整将是数十年来美国联邦大麻政策最重大的变革之一，将为研究该药物的潜在用途清除障碍。
路透社伊朗简报通讯将为您带来伊朗局势的最新动态与分析，点击此处订阅。
广告 · 滚动继续阅读
去年12月，美国总统唐纳德·特朗普签署行政令，要求放松联邦层面的大麻监管规定，为大麻分类调整铺平道路。
此次调整或将使这种精神活性植物被列为与普通止痛药、氯胺酮和睾酮同一类别的低风险药物。
此举还可能重塑大麻行业，降低企业税负，并帮助公司更容易获得融资，惠及Canopy Growth（股票代码：WEED.TO）、Tilray Brands（股票代码：TLRY.TO）、Trulieve Cannabis（股票代码：TRUL.CD）等企业。
Axios报道发布后，在美上市的Canopy Growth股价暴涨23%，Tilray股价上涨15%。
广告 · 滚动继续阅读
美国司法部及其毒品 Enforcement 管理局（DEA）未立即回应置评请求。大麻分类调整的最终决定权在DEA手中。
大麻是全球及美国使用最广泛的违禁毒品。据路透社去年12月报道，美国疾病控制与预防中心数据显示，近五分之一的美国居民每年都会使用大麻。
Bhargav Acharya与Daphne Psaledakis报道，Padmanabhan Ananthan补充报道，Caitlin Webber编辑
我们的报道准则：汤森路透信托原则，点击此处查看
US set to move to reclassify marijuana as early as Wednesday, Axios reports
2026-04-22 4:13 PM UTC / Reuters
By Reuters
April 22, 2026 4:13 PM UTC Updated 2 hours ago
节点运行失败
A woman carries a marijuana plant as she attends the annual NYC Cannabis Parade at the Manhattan borough in New York City, U.S., May 4, 2024. REUTERS/Eduardo Munoz Purchase Licensing Rights, opens new tab
WASHINGTON, April 22 (Reuters) – The United States administration is expected to move to reclassify marijuana as soon as Wednesday, Axios reported, citing an official familiar with the matter, sending U.S. stocks of cannabis-related companies higher.
The decision to reclassify marijuana would represent one of the most significant federal changes to marijuana policy in decades, removing barriers to researching the drug’s potential use cases.
The Reuters Iran Briefing newsletter keeps you informed with the latest developments and analysis of the Iran war. Sign up here.
Advertisement · Scroll to continue
In December, U.S. President Donald Trump signed an executive order directing the loosening of federal regulations on marijuana, paving the way for reclassification.
The move could lead to the psychoactive plant being listed alongside common painkillers, ketamine and testosterone as a less dangerous drug.
It would also likely reshape the cannabis industry by lowering tax burdens and make it easier for companies to secure funding, benefiting firms like Canopy Growth WEED.TO, opens new tab, Tilray Brands TLRY.TO, opens new tab, Trulieve Cannabis TRUL.CD, opens new tab.
U.S.-listed shares of Canopy surged 23% while Tilray rose 15% following the Axios report.
Advertisement · Scroll to continue
The Justice Department and its Drug Enforcement Administration did not immediately respond to requests for a comment. The decision to reclassify marijuana rests with the DEA.
Marijuana is the most widely used illicit drug in the world and the United States. Nearly one in five U.S. residents use it a year, according to the U.S. Centers for Disease Control and Prevention, Reuters reported in December.
Reporting by Bhargav Acharya and Daphne Psaledakis, additional reporting by Padmanabhan Ananthan; editing by Caitlin Webber
Our Standards: The Thomson Reuters Trust Principles., opens new tab
发表回复